英文報告（１）英文原著
No. Author

Title

JournalVol.

Page

Year

Characteristics of the mechanosensitive bladder afferent activities inrelation with microcontractions in male rats with bladder outletobstruction.

Sci Rep

77646

2017

2017

1

Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson K.E, Homma Y,Igawa Y.

2

Aizawa N, Ito H, Sugiyama R, Fujimura T, Fukuhara H, Kume H, Homma Y, Effects of Sildenafil, a Phosphodiesterase Type 5 Inhibitor, on the Primary
Igawa Y.
Single Afferent Activity of the Rat Bladder.

Low Urin Tract
9Symptoms

57-61

3Inhibitory effects of retigabine, a Kv7 channel activator, onAizawa N, Wakamatsu D, Kida J, Otsuki T, Saito Y, Matsuya H, Homma Y,
mechanosensitive primary bladder afferent activities and nociceptive
Igawa Y.
behaviors in rats.

Neurourol
Urodyn36280-285 2017

4Fujimura T, Fukuhara H, Taguchi S, Yamada Y, Sugihara T, Nakagawa T,
Niimi A, Kume H, Igawa Y, Homma Y.

BMC Cancer

174542017

5Gong, X., Z. Siprashvili, O. Eminaga, Z. Shen, Y. Sato, H. Kume, Y. Homma,
Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
S. Ogawa, P. A. Khavari, J. R. Pollack and J. D. Brooks

Oncotarget

81865718669

2017

Robot-assisted radical prostatectomy significantly reduced biochemicalrecurrence compared to retro pubic radical prostatectomy.

Homma Y, Gotoh M, Kawauchi A, Kojima Y, Masumori N, Nagai A, Saitoh
6 T, Sakai H, Takahashi S, Ukimura O, Yamanishi T, Yokoyama O, Yoshida
M, Maeda K.

Clinical guidelines for male lower urinary tract symptoms and benign
prostatic hyperplasia.

Int J Urol

24716-729 2017

7Ichihara K, Aizawa N, Akiyama Y, Kamei J, Masumori N, Andersson K.E,Homma Y, Igawa Y.

Toll-like receptor 7 is overexpressed in the bladder of Hunner-type
interstitial cystitis, and its activation in the mouse bladder can induce
cystitis and bladder pain.

Pain

158

15381545

8Kamei J, Yagihara Y, Kume H, Horiuchi T, Sato T, Nakagawa T, FujimuraT, Fukuhara H, Moriya K, Homma Y.

Prevalence and characteristics of fecal antimicrobial-resistant Escherichia
Int J Urolcoli in a cohort of Japanese men undergoing prostate biopsy.

24295-300 2017

9Koyama Y, Morikawa T, Miyakawa J, Miyama Y, Nakagawa T, Homma Y,Fukayama M.

Diagnostic utility of Ki-67 immunohistochemistry in small endoscopic
biopsies of the ureter and renal pelvis.

213737-741 2017

Pathol ResPract2017

No. Author
10

Makino K, Nakagawa T, Kanatani A, Kawai T, Taguchi S, Otsuka M,
Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Homma Y.

11 Misawa A, Takayama K.I, Fujimura T, Homma Y, Suzuki Y, Inoue S.

Title

JournalBiphasic decline in renal function after radical cystectomy with urinarydiversion.

Int J Clin Oncol 22359-365 2017

Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related
pathway to facilitate cell survival in prostate cancer cells.

Cancer Sci

373-379 2017

Loss of Stromal Antigen 2 (STAG2) Expression in Upper Urinary Tract
Carcinoma: Differential Prognostic Effect According to the Ki-67
Proliferating Index.

Ann Surg Oncol 2412Miyakawa J, Morikawa T, Miyama Y, Nakagawa T, Kawai T, Homma Y,Fukayama M.

13Miyazaki H, Hirano Y, Kato S, Ioritani N, Ichikawa T, Takamoto H, Homma Early Experiences of Contact Laser Vaporization of the Prostate using the Low Urin TractY.
980 nm High Power Diode Laser for Benign Prostatic Hyperplasia.
Symptoms.

14

Naito A, Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Tabata M,
Miyakawa J, Suzuki M, Nishimatsu H, Enomoto Y, S. Takahashi S,Okaneya T, Yamada D, Tachikawa T, Minowada S, Fujimura T, FukuharaH, Kume H, Homma Y.

Vol.

108

Page40594066

Year

2017

2017

Prognostic significance of serum neuron-specific enolase in small cell
carcinoma of the urinary bladder.

World J Urol35

97-1032017

Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y,
Efficacy of post-nephroureterectomy cisplatin-based adjuvant
Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka
15
chemotherapy for locally advanced upper tract urothelial carcinoma: aY, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y,
multi-institutional retrospective study.
Homma Y.

World J Urol

3515691575

2017Nakagawa T, Taguchi S, Kanatani A, Kawai T, Ikeda M, Urakami S,Matsumoto A, Komemushi Y, Miyakawa J, Yamada D, Suzuki M, Enomoto Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is
16
Y, Nishimatsu H, Kondo Y, Nagase Y, Hirano Y, Okaneya T, Tanaka Y,
the Best Candidate?
Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.

Ann Surg Oncol 2427942800

2017Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A,Yoshida K, Kawai T, Nagata M, Yamada D, Komemushi Y, Suzuki M,
17 Enomoto Y, Nishimatsu H, Ishikawa A, Nagase Y, Kondo Y, Tanaka Y,Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Fukuhara H,Kume H, Igawa Y, Homma Y.

Urol Oncol

35457e4152017
457 e421

Nomogram for predicting survival of postcystectomy recurrent urothelial
carcinoma of the bladder.

18Sugihara T, Ishikawa A, Takamoto T, Kinoshita Y, Minami T, Yamada Y,Homma Y, Makuuchi M.

"Three-Dimensional Volume Rendering of Entrapped Malecot Nephrostomy
Urol Case Rep
Catheter by Granulation Tissue.

1264-66

19

Sugihara T, Yasunaga H, Matsui H, Nagao G, Ishikawa A, Fujimura T,
Fukuhara H, Fushimi K, Ohori M, Homma Y.

Accessibility to surgical robot technology and prostate-cancer patient
behavior for prostatectomy.

47647-651 2017

Jpn J Clin
Oncol

2017

No. Author

Title

JournalVol.

PageYear2017

20

Sugiyama R, Aizawa N, Ito H, Fujimura T, Suzuki M, Nakagawa T,Fukuhara H, Kume H, Homma Y, Igawa Y.

Synergic Suppressive Effect of Silodosin and Imidafenacin on Non-Voiding
Bladder Contractions in Male Rats with Subacute Bladder Outlet
Obstruction.

Low Urin Tract
9Symptoms

94-101

21

Taguchi S, Buti S, Fukuhara H, Otsuka M, Bersanelli M, Morikawa T,
Miyazaki H, Nakagawa T, Fujimura T, Kume H, Igawa Y, Homma Y.

Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or areality?

PLoS Onee0172341 201722Takayama K. I , Suzuki T, Fujimura T, Yamada Y, Takahashi S, Homma Y,Suzuki Y, Inoue S.

Dysregulation of spliceosome gene expression in advanced prostate cancer Proc Natl Acad114
by RNA-binding protein PSF.
Sci U S A

1046110466

23

Tsuda Y, Nakagawa T, Shinoda Y, Kanatani A, Kawai T, Taguchi S,Yamada Y, Sawada R, Kume H, Homma Y, Tanaka S, Kawano H.

Skeletal-related events and prognosis in urothelial cancer patients withbone metastasis.

Int J Clin Oncol 22548-553 2017

24Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Miyazaki H, Nakagawa T,Kume H, Igawa Y, Homma Y.

Overactive bladder is a negative predictor of achieving continence after
robot-assisted radical prostatectomy.

Int J Urol

749-756 201725

Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Nakagawa T, Kume H,Igawa Y, Homma Y.

Predictors of Early Continence after Robot-assisted Radical
Prostatectomy.

Low Urin Tract
Symptoms

26

YamadaY, Fujimura T, Fukuhara H, Sugihara T, Takemura K, Kakutani S,Suzuki M, Nakagawa T, Kume H, Igawa Y, Homma Y.

Incidence and risk factors of inguinal hernia after robot-assisted radicalprostatectomy.

World J SurgOncol

272812242017

2017

1561

2017

Yamada Y, Takayama K.I, Fujimura T, Ashikari D, Obinata D, Takahashi S, A novel prognostic factor TRIM44 promotes cell proliferation and migration,Cancer Sci
Ikeda K, Kakutani S, Urano T, Fukuhara H, Homma Y, Inoue S.
and inhibits apoptosis in testicular germ cell tumor.

10832-41

2017

Yokoyama O, Nishizawa O, Homma Y, Takeda M, Gotoh M, Kakizaki H,Akino H, Hayashi K, Yonemoto K, Group O.P.

29 Matsushima H.

Nocturnal Polyuria and Hypertension in Patients with Lifestyle RelatedDiseases and Overactive Bladder.

J Urol

197

423-431 2017

Androgen deprivation therapy induces vitamin K loss in men with prostatecancer.

Biol Med9404-409 2017

No. Author
30

Hakozaki Y, Matsushima H, Kumagai J, Murata T, Masuda T, Hirai Y, Oda
M, Kawauchi N, Yokoyama M, Homma Y.

Nakamura M, Zhang Y, Yang Y, Sonmez C, Zheng W, Huang G, Seki T,
31 Iwamoto H, Ding B, Yin L, Foukakis T, Hatschek T, Li X, Hosaka K, Li J,Yu G, Wang X, Liu Y, Cao Y.

Title
JournalA prospective study of magnetic resonance imaging and ultrasonography(MRI/US)-fusion targeted biopsy and concurrent systematic transperineal
BMC urology
biopsy with the average of 18-cores to detect clinically significant prostatecancer.
Off-tumor targets compromise antiangiogenic drug sensitivity by inducing
kidney erythropoietin production.

PNASVol.

PageYear

17117-122 2017

114(45)

E9635E96442017Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y,Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Oncological Outcome of Metastasectomy for Urothelial Carcinoma: Who is32
Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y,
the Best Candidate?
Homma Y.

Ann Surg Oncol 2727942800

2017

Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y,
Efficacy of post-nephroureterectomy cisplatin-based adjuvantKanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka
33
chemotherapy for locally advanced upper tract urothelial carcinoma: aY, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y,
multi-institutional retrospective study.
Homma Y.

World J Urol35

15691575,

2017

2017

Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Takemura K, Kakutani S,Suzuki M, Nakagawa T, Kume H, Igawa Y, Homma Y.

Incidence and risk factors of inguinal hernia after robot-assisted radicalprostatectomy.

World J Surg
Oncol

1561

Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A,Yoshida K, Kawai T, Nagata M, Yamada D, Komemushi Y, Suzuki M,
35 Enomoto Y, Nishimatsu H, Ishikawa A, Nagase Y, Kondo Y, Tanaka Y,Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Fukuhara H,
Kume H, Igawa Y, Homma Y.

Nomogram for predicting survival of postcystectomy recurrent urothelial
carcinoma of the bladder.

Urol Oncol

35457.e152017
457.e2136 Yoshida M, Igawa Y, Higashimura S, Suzuki M, Niimi A, Sanada H.

Translation and reliability and validity testing of a Japanese version of theIntermittent Self-Catheterization Questionnaire.

Neurourol
Urodynam

3613561362

2017

Validation of a new prognostic model to easily predict outcome in renal cell
Ann Oncol
carcinoma: the GRANT score applied to the ASSURE trial population.

2827472753

2017

Translation and reliability and validity testing of a Japanese version of theIntermittent Self-Catheterization Questionnaire among disposable andreusable catheter users

Neurourol
Urodyn3613561362

2017

Clinical characteristics of testicular germ cell tumors in patients aged 50years and older: A large-scale study from the Cancer Registration
Committee of the Japanese Urological Association.

Int J Urol

24124-128 2017

34

37

Buti S, Puligandla M, Bersanelli M, DiPaola R, Manola J, Taguchi S, Haas
NB.

38 Yoshida M, Igawa Y, Higashimura S, Suzuki M, Niimi A, Sanada H.

39

Kawai T, Tanaka Y; Cancer Registration Committee of the Japanese
Urological Association.

No. Author

Title

Obara W, Eto M, Mimata H, Kohri K, Mitsuhata N, Miura I, Shuin T, Miki T,
A phase I/II study of cancer peptide vaccine S-288310 in patients with40 Koie T, Fujimoto H, Minami K, Enomoto Y, Nasu T, Yoshida T, Fuse H,advanced urothelial carcinoma of the bladder.
Hara I, Kawaguchi K, Arimura A, Fujioka T.

Journal

Vol.

Page

Year

Ann Oncol

28798-8-3 2017

英文報告（２）英文総説
No. Author

Title

JournalVol. Page

Year

1 Igawa Y, Aizawa N.

Incontinence: How do β3-adrenoceptor agonists work in the bladder?

Nat Rev Urol14330-332

2017

2 Ito H, Pickering AE, Igawa Y, Kanai AJ, Fry CH, Drake MJ.

Muro-Neuro-Urodynamics; a review of the functional assessment ofmouse lower urinary tract function.

Front Physiol

849

2017

3 Taguchi S, Fukuhara H, Homma Y, Todo T.

Current status of clinical trials assessing oncolytic virus therapy for
urological cancers.

Int J Urol

24342-351

20174

Horita S, Nakamura M, Suzuki M, Satoh N, Suzuki A, Homma Y, Nangaku
M.

The role of renal proximal tubule transport in the regulation of bloodpressure.

Kidney Res Clin
36
Pract12-21

2017

5Sawada R, Shinoda Y, Niimi A, Nakagawa T, Ikegami M, Kobayashi H,Homma Y, Haga N, Tanaka S.

Multiple acrometastases in a patient with renal pelvic urothelial cancer.

Case Rep Urol.

7830207

2017

英文報告
（３）英文症例報告
No. Author
1

Sugihara T, Ishikawa A, Takamoto T, Kinoshita Y, Minami T, Yamada Y,Homma Y, Makuuchi M.

Ikeda M, Kobayashi T, Suzuki T, Wakabayashi Y, Ohama Y, Maekawa S,
2 Takahashi S, Homma Y, Tatsuno K, Sato T, Okugawa S, Moriya K,
Yotsuyanagi H.

3TitleJournalVol. Page

Year

Three-Dimensional Volume Rendering of Entrapped Malecot
Nephrostomy Catheter by Granulation Tissue.

Urol Case Rep

1264-62017

Propionimicrobium lymphophilum and Actinotignum schaalii bacteremia
with urinary tract infection: a case report.

New Microbes
New Infect1818-212017

Respir MedCase Rep

22

158-163 2017

Matsuki R, Okuda K, Mitani A, Yamauchi Y, Tanaka G, Kume H, Homma Y, A case of delayed exacerbation of interstitial lung disease after
Hinata M, Hayashi A, Shibahara J, Fukayama M, Nagase T.
discontinuation of temsirolimus.

英文報告（４）英文その他
No. Author

Title

Book namePage

Editors

Publication

Year

Salvatore S, Rademakers K, DeLancey J, Igawa Y, Koelbl H,
1Laterza RM, Serati M, Sultan A, Sievert KD, Lowry A.

Pathophysiology of urinary incontinence, faecal incontinence,and pelvic organ prolaps.

Incntinence
6th Edition

Abrams P,
Cardozo361-495
ICS ICUD 2016 2017
L, Wagg A,Wein A

英文報告（４）英文その他
No. Author
1 Taguchi S, Fukuhara H, Homma Y.

2 Igawa Y.

Title
Journal
Re: Very Early Salvage Radiotherapy Improves Distant MetastasisFree Survival: A. Abugharib, W. C. Jackson, V. Tumati, R. T. Dess, J. Y.
J UrolLee, S. G. Zhao, M. Soliman, Z. S. Zumsteg, R. Mehra, F. Y. Feng, T. M.
Morgan, N. Desai and D. E. Spratt J Urol 2017;197:662-668.
Manaing LUTS: Alpha-blockers: A relief for benign prostaticobstruction or only for LUTS improvement?

Vol.

Page

198

212-214 2017

EuropeanFirst
Urology Today
5edition
Congress NewsYear2017